IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Sun Yat-sen University
Jiangsu HengRui Medicine Co., Ltd.
Roswell Park Cancer Institute
Merck Sharp & Dohme LLC
Radiation Therapy Oncology Group
University of Washington
Bristol-Myers Squibb
Thomas Jefferson University
Bristol-Myers Squibb
CHA University
Cedars-Sinai Medical Center
Mayo Clinic
Milton S. Hershey Medical Center
University of Southern California
Eisai Inc.
BeiGene
Merck Sharp & Dohme LLC
Sanofi
Hoffmann-La Roche
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Incyte Corporation
M.D. Anderson Cancer Center
Bayer
Thomas Jefferson University
Thomas Jefferson University
Ethicon, Inc.
Fundacion Clinic per a la Recerca Biomédica
BeiGene
Imperial College London
Boston Scientific Corporation
Bristol-Myers Squibb
Sarcoma Oncology Research Center, LLC
University of California, San Francisco
Sirtex Medical
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
TopAlliance Biosciences
Chinese University of Hong Kong
University of Nebraska
BeiGene
BeiGene
Canadian Cancer Trials Group
Novartis
Beijing YouAn Hospital
Beijing YouAn Hospital
Merck Sharp & Dohme LLC
Astex Pharmaceuticals, Inc.
Imunon
National Cancer Institute (NCI)